complexion chang oral contracept user result phase IV multicent trial safeti efficaci ethynodiol diacet mg ethinyl estradiol microgram open-label phase IV multicent survey obstetrician-gynecologist efficaci safeti low-dos monophas oral contracept ethynodiol diacet mg ethinyl estradiol microgram survey community-bas physician women patient notic complexion chang patient complexion chang three-fourth improv follow-up questionnair respond worsen complexion questionnair complexion worsen slight degre patient physician first month literatur mani refer condit improv oral contracept report descript studi clinician estim incid sever complexion chang actual use 